Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
| NAV6/7/2023 | Chg.-1.6100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 301.5600EUR | -0.53% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.24 | 8.73 | -8.18 | 11.89 | -1.92 | 3.11 | -10.47 | 12.83 | -2.22 | - |
| 2017 | 3.03 | 8.72 | -0.49 | -0.67 | -5.96 | 7.91 | -0.89 | 5.99 | 1.53 | -5.17 | -2.11 | 0.80 | +12.13% |
| 2018 | 2.91 | -2.52 | -2.89 | -1.42 | 8.33 | 0.84 | 4.25 | 4.77 | -1.87 | -11.81 | 4.26 | -9.14 | -6.05% |
| 2019 | 12.77 | 4.42 | 0.90 | -4.71 | -3.87 | 7.14 | 0.09 | -1.23 | -3.48 | 8.72 | 13.36 | 1.02 | +38.52% |
| 2020 | -4.00 | -0.60 | -4.83 | 12.62 | 7.87 | 0.37 | -7.82 | -0.23 | 2.77 | -1.95 | 6.65 | 0.73 | +10.25% |
| 2021 | 2.59 | -2.45 | -1.09 | 0.34 | -3.37 | 9.30 | -1.40 | 4.43 | -2.41 | 0.36 | -1.64 | 1.42 | +5.54% |
| 2022 | -9.24 | -1.70 | 7.12 | -2.10 | -5.38 | 6.12 | 7.42 | 3.02 | 0.75 | 5.62 | 1.98 | -6.23 | +5.80% |
| 2023 | 1.20 | -3.34 | -2.09 | 0.70 | 2.65 | 2.02 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 17.63% | 17.80% | 22.73% | 22.24% | 24.10% |
| Sharpe ratio | -0.06 | -0.42 | 0.64 | 0.06 | 0.24 |
| Best month | +2.65% | +2.65% | +7.42% | +9.30% | +13.36% |
| Worst month | -6.23% | -6.23% | -6.23% | -9.24% | -11.81% |
| Maximum loss | -9.39% | -10.78% | -13.58% | -19.54% | -27.31% |
| Outperformance | -2.53% | - | -0.31% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,891.0699 | +17.14% | +7.98% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 206.2000 | +17.03% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,934.4399 | +12.98% | +1.00% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,061.4099 | +16.90% | +13.54% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,186.9500 | +17.93% | +8.51% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 334.3600 | +19.23% | +11.38% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 301.5600 | +18.07% | +15.35% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 192.7800 | +12.80% | +1.12% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,689.2900 | +18.39% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,198.0098 | +17.31% | +8.02% | |
| Candriam Equities L Biotech.V US... | reinvestment | 557.1500 | +16.64% | +5.30% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 186.4400 | +13.87% | +0.38% | |
| Candriam Equities L Biotech.R US... | reinvestment | 246.3600 | +18.53% | +9.70% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 192.8400 | +14.17% | +2.77% | |
| Candriam Equities L Biotech.C US... | reinvestment | 779.3300 | +17.12% | +6.74% | |
| Candriam Equities L Biotech.C US... | paying dividend | 716.1000 | +17.08% | +6.63% |
Performance
| YTD | +1.00% | ||
|---|---|---|---|
| 6 Months | -1.98% | ||
| 1 Year | +18.07% | ||
| 3 Years | +15.35% | ||
| 5 Years | +55.46% | ||
| 10 Years | - | ||
| Since start | +101.04% | ||
| Year | |||
| 2022 | +5.80% | ||
| 2021 | +5.54% | ||
| 2020 | +10.25% | ||
| 2019 | +38.52% | ||
| 2018 | -6.05% | ||
| 2017 | +12.13% | ||